ATSN-101 Gene Therapy Reports Positive Data in Phase 1/2 Trial HCP Live, 10 Sep 2024 Artur Cideciyan, PhD Credit: LinkedIn ATSN-101 subretinal gene therapy demonstrated a robust safety profile and preliminary…